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The endocytic and autophagic pathways are involved in the membrane trafﬁcking of exogenous and endogenous materials to
lysosomes. However, the mechanisms that regulate these pathways are largely unknown. We previously reported that Rubicon,
a Beclin 1–binding protein, negatively regulates both the autophagic and endocytic pathways by unidentiﬁed mechanisms. In
this study, we performed database searches to identify potential Rubicon homologues that share the common C-terminal
domain, termed the RH domain. One of them, PLEKHM1, the causative gene of osteopetrosis, also suppresses endocytic
transport but not autophagosome maturation. Rubicon and PLEKHM1 speciﬁcally and directly interact with Rab7 via their RH
domain, and this interaction is critical for their function. Furthermore, we show that Rubicon but not PLEKHM1 uniquely
regulates membrane trafﬁcking via simultaneously binding both Rab7 and PI3-kinase.
INTRODUCTION
Endocytosis involves the intracellular transport of extracellular
and plasma membrane substrates to endosomes/lysosomes
and is involved in many physiological processes (Mukherjee et
al., 1997). Autophagy is also a process in which cytoplasmic
constituents, including organelles, are transported within dou-
ble-membraned autophagosomes to lysosomes for degrada-
tion (Xie and Klionsky, 2007; Yoshimori and Noda, 2008). Au-
tophagy has divergent physiological roles in cancer, infection,
immunity, and other processes (Mizushima et al., 2008). Many
reports suggest there is a common element between the endo-
somal and autophagic pathways (Raiborg and Stenmark, 2009;
Simonsen and Tooze, 2009), but these commonalities have not
been fully elucidated.
Recently, two groups identiﬁed an interesting protein, Ru-
bicon, that may link these two pathways (Matsunaga et al.,
2009; Zhong et al., 2009). Rubicon was identiﬁed as a protein
that binds to Beclin 1, a tumor suppressor protein and mam-
malian homologue of the yeast autophagy protein Atg6/Vps30
(Liang et al., 1999; Kihara et al., 2001a). Yeast Atg6/Vps30
facilitates two distinctive processes: autophagy and retrograde
trafﬁc from endosomes to the Golgi apparatus by two different
phosphatidylinositol 3-kinase (PI3-kinase) complexes: class I
(Atg14, Atg6, Vps34, Vps15) and class II (Atg38, Atg6, Vps34,
Vps15) (Kihara et al., 2001b). Mammalian Beclin 1 has a similar,
albeit distinct, complex organization. One complex consists of
Beclin 1, hAtg14L/Atg14/Barkor, hVps34, and p150/hVps15
and acts in autophagosome formation (Itakura et al., 2008; Sun
et al., 2008; Matsunaga et al., 2009; Zhong et al., 2009). Another
complex contains Beclin 1, UVRAG, hVps34, and p150/hVps15
and functions in the endocytic pathway and autophagosome–
lysosome fusion (Liang et al., 2006; Itakura et al., 2008; Liang et
al., 2008). A third Beclin 1 complex includes Rubicon and the
UVRAG complex (Matsunaga et al., 2009). Knockdown of Ru-
bicon enhances endocytic transport and autophagosome–lyso-
some fusion (Matsunaga et al., 2009; Zhong et al., 2009). In
addition, autophagy is induced even in the absence of nutrient
starvation (Matsunaga et al., 2009; Zhong et al., 2009). Thus, the
third complex negatively regulates both the endocytic and
autophagic pathways. A Rubicon homologue has not been
identiﬁed in yeast, suggesting that this potential complex reg-
ulatory mechanism is speciﬁc to higher eukaryotes. However,
it is unclear how Rubicon regulates membrane trafﬁc.
To further determine the function of Rubicon, we searched
mammalian gene databases for Rubicon homologues. As a
result, we identiﬁed PLEKHM1, which also contains an RH
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4162domain and is reportedly a causative gene for osteopetrosis
due to mutations, but the mechanisms remain unknown (Van
Wesenbeeck et al., 2007). Rubicon and PLEKHM1 share a com-
mon C-terminal domain, which we termed the RH (Rubicon
homologous) domain. Here, we show that the RH domains of
Rubicon and PLEKHM1 speciﬁcally interact with Rab7, a Rab
GTPase that localizes to the late endosome/lysosome. These
interactions are necessary for their functions in the endocytic
pathway. In addition to binding to Rab7, Rubicon, but not
PLEKHM1, also associates with the Beclin 1–PI3-kinase com-
plex. Synchronous associations of Rubicon with the Beclin
1-PI3-kinase complex and Rab7 are necessary to regulate the
endocytic and autophagic pathways. These ﬁndings provide




HeLa, MCF7, human embryonic kidney (HEK)293A, and A549 cells were
cultured in DMEM D6546 (Sigma, St. Louis, MO) containing 10% fetal bovine
serum supplemented with 4 mM L-glutamine in 5% CO2 at 37°C. Cells were
transiently transfected using Lipofectamine 2000 Reagent (Invitrogen, Carls-
bad, CA) according to the manufacturer’s protocol.
Plasmid Construction
The plasmids encoding monomeric red ﬂuorescent protein (mStrawberry) and
mCherry were generously provided by Dr. Roger Y. Tsien (Shaner et al., 2004).
The cDNAs encoding Rab5 WT, Rab5 Q79L, Rab5 S34N, Rab7 WT, Rab7 Q67L,
and Rab7 T22N derived from Madin-Darby canine kidney (MDCK) cells were
gifts from Dr. K. Umebayashi. Human Rab9 cDNA was reverse transcribed and
subcloned into the polymeric enhanced green ﬂuorescent protein (pEGFP)-C1
vector (Clontech, Palo Alto, CA). pEGFP-LC3 (Kabeya et al., 2000) and mouse
Rubicon (mRubicon) cDNA (Matsunaga et al., 2009) were previously described.
The human Rubicon (hRubicon) was reverse transcribed using RNA extracted
from A549 cells. For yeast two-hybrid analysis, the pGAD-C1 vector, pGBD-C1
vector and PJ69–4A strain were kingly provided by Dr. P. James (James et al.,
1996). cDNA encoding human PLEKHM1 (hPLEKHM1), also known as
KIAA0356, was kindly provided by the Kazusa DNA Research Institute
(Kisarazu, Japan). The PLEKHM1 (FL_CGHL) and Rubicon (FL_CGHL) mutants
were generated by site-direct mutagenesis.
Antibodies and Reagents
Rabbit polyclonal anti-PLEKHM1 antibodies were raised against a recombi-
nant protein encoding the C-terminal 300 amino acids, which were subcloned
into the KpnI-XbaI sites of the pCold II DNA vector (TAKARA Bio, Tokyo,
Japan). The plasmids were transformed into BL2 competent cells. The ex-
pressed protein was eluted from an SDS polyacrylamide gel, and the puriﬁed
recombinant protein was used to immunize rabbits. The rabbit antisera
against PLEKHM1 were afﬁnity-puriﬁed using the same recombinant protein.
The following additional antibodies were used: rabbit polyclonal anti-FLAG
(Sigma), mouse monoclonal anti-FLAG M2 (Sigma), rabbit polyclonal anti-Myc
(MBL, Nagoya, Japan), rabbit polyclonal anti-GFP (MBL), rabbit polyclonal anti-
RFP (MBL), rabbit polyclonal anti-LC3 (PM036, MBL), mouse monoclonal anti-
EEA1 (BD Transduction Laboratories, Lexington, KY), mouse monoclonal anti-
LAMP-1 (H4A3; Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal
anti--tubulin (B5–1-2; Sigma), and sheep polyclonal anti-EGFR (Fitzgerald In-
dustries, Concord, MA) antibodies. Rabbit polyclonal antibodies against Beclin 1,
UVRAG, hVps34, p150 (hVps15), and Rubicon were previously described
(Kihara et al., 2001a; Matsunaga et al., 2009).
Preparation of Recombinant PLEKHM1 and Rubicon
Proteins
cDNA encoding PLEKHM1 (FL) or Rubicon (FL) was subcloned into pCold
TF DNA (TAKARA Bio). Recombinant proteins were expressed in BL21 cells
and puriﬁed with Ni-NTA (Qiagen) according to manufacturer’s instructions.
In vitro Glutathione S-transferase Pulldown Assay
In vitro glutathione S-transferase (GST) pulldown assays were performed as
previously described (Christoforidis and Zerial, 2000) with some modiﬁca-
tions. Brieﬂy, to prepare the inactive and active forms of GST-Rab7 by
nucleotide exchange, buffer 1 (50 mM Tris-HCl, pH 8.0, 2.5 mM DTT, 25 mM
EDTA, and 12.5 mM MgCl2) containing 20 M GDP or GTPS and buffer 2 (20
mM Tris-Cl, pH 8.0, 1 mM DTT, 1 mM EDTA, 5 mM MgCl2, and 0.6%
CHAPS) containing GST-Rab7 were mixed and incubated for 10 min at 30°C.
Subsequently, MgCl2 at a ﬁnal concentration of 10 mM was added to this
mixture to stabilize the nucleotides. GDP- or GTPS-loaded GST-Rab7 was
incubated with glutathione Sepharose 4B (GE Heathcare Bioscience, Piscat-
away, NJ) for1ha t4 ° Ca n dwashed three times with buffer 3 (20 mM Tris-Cl,
pH 8.0, 1 mM DTT, 1 mM EDTA, 5 mM MgCl2, and 0.3% CHAPS) and once
with buffer 4 (20 mM Tris-Cl, pH 8.0, 1 mM DTT, 1 mM EDTA, and 5 mM
MgCl2). Next, recombinant PLEKHM1 or Rubicon was added to the GST-
Rab7 beads and incubated for2ha t4°C. Then, the beads were washed three
times with buffer 4 and eluted with SDS-sample buffer. The samples were
subjected to SDS-PAGE followed by immunoblotting.
Immunoblot Analysis
Cells were washed with ice-cold PBS, scraped, collected by centrifuging at 4°C,
and then lysed in lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton
X-100, 1 mM phenylmethylsulfonyl ﬂuoride, and a protease inhibitor cocktail;
Roche, Mannheim, Germany) for 10 min on ice. The lysates were centrifuged at
15,000  g for 10 min at 4°C, and the supernatants were collected. The samples
were separated by SDS-PAGE and transferred to PVDF membranes. The mem-
branes were blocked with 3% skim milk in 0.1% Tween-20/TBS and then incu-
bated with the appropriate primary antibodies. When either the anti-PLEKHM1
antibody or anti-Rubicon antibody was used, the membranes were incubated in
Can Get Signal Solution I (Toyobo, Tokyo, Japan) overnight at 4°C. Immunore-
active bands were detected using horseradish peroxidase–conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) and lumi-
nol solution (ECL plus; GE Healthcare Bioscience).
Adenoviral Overexpression System
3xFLAG-hPLEKHM1 was subcloned into the pENTR-1A plasmid (Invitrogen).
The cDNA insert was subcloned into the pAd/CMV/V5-DEST vector (Invitro-
gen) using the Gateway system with LR clonase (Invitrogen). Recombinant
adenovirus was prepared with the ViraPower Adenovirus Expression System
(Invitrogen) according to the manufacturer’s instructions. Adenovirus infections
were performed as follows. One day before infection, 2  105 cells were seeded
into six-well plates and incubated overnight at 37°C in a CO2 incubator. The
medium was then replaced with 2 ml of culture medium containing recombinant
adenoviruses. After a 12-h incubation, the medium was replaced with 2 ml of
culture medium. At 48 h after infection, the cells were used for experiments.
Adenovirus Small Hairpin RNA Expression System
hPLEKHM1 or hRubicon was knocked down using an adenovirus vector-based
shRNA. The RNAi oligonucleotide sequences for hRubicon and GL2 luciferase
(negative control) were previously described (Matsunaga et al., 2009). The target
sequences for hPLEKHM1 were chosen using the siDirect algorithm (http://
design.rnai.jp) and are located at base pairs 909–931 (5-CCGGTCTCTGCAA-
GAGGTATTGT-3). Oligonucleotides pairs were designed from these target
sequences based on the Block-iT U6 RNAi Entry Vector Kit (Invitrogen). These
pairs were annealed, ligated into the pENTR/U6 vector (Invitrogen), and trans-
ferred into the pAd/BLOCL-iT DEST vector (Invitrogen) through an LR recom-
bination reaction (Invitrogen). The recombinant adenovirus was generated using
ViraPower Adenoviral technology (Invitrogen). For knockdown analysis, sub-
conﬂuent A549 cells in 35-mm dishes were infected with adenovirus and trans-
ferred to 60-mm dishes after 12 h. After an additional 24 h, the cells were
reinfected with the virus. The medium was changed after an additional 12 h. At
5 d after infection, the cells were subjected to experiments.
Yeast Two-Hybrid Analysis
The yeast two-hybrid protocol was previously described (James et al., 1996).
The yeast strain PJ69–4A was transformed with pGBD-Rab and pGAD-
hPLEKHM1 or pGAD-hRubicon. Transformants were grown on a yeast ni-
trogen base that was supplemented with or without histidine and contained
2.5 mM 3-amino-1,2,4-triazole (3-AT) at 30°C for 3–4 d.
Fluorescence and Immunoﬂuorescence Microscopy
Cells were cultured on coverslips and then ﬁxed with 3% paraformaldehyde
in PBS for 20 min. For immunoﬂuorescence microscopy, the cells were per-
meabilized with 50 g/ml digitonin in PBS for 10 min at room temperature.
The permeabilized cells were incubated in blocking solution (0.1% gelatin in
PBS) and then stained with primary and secondary antibodies diluted in
blocking solution. The coverslips were mounted in Slowfade Gold Reagent
(Invitrogen), and images were obtained with an Olympus FV1000 laser scan-
ning confocal microscope (Olympus, Tokyo, Japan).
Immunoprecipitation
Cells were lysed with lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
10% [wt/vol] glycerol, 100 mM NaF, 10 mM EGTA, 1 mM Na3VO4, 1% Triton
X-100, 5 M ZnCl2, 1 mM phenylmethylsulfonyl ﬂuoride, and a protease
inhibitor cocktail; Roche). The cell lysates were clariﬁed by centrifuging at
15,000 rpm for 10 min at 4°C. The supernatants were immunoprecipitated
with FLAG M2 agarose beads (Invitrogen) or the indicated primary antibody
and protein G-Sepharose 4FF (GE Healthcare Bioscience). Immunocomplexes
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NaCl, and 0.1% Triton X-100) and then subjected to immunoblot analysis.
EGF Transport to Labeled Lysosomes
A549 cells were incubated with 0.1 mg/ml dextran-conjugated tetramethyl-
rhodamine (70,000 MW; Invitrogen) in DMEM containing 10% FBS for 16–18
h. The cells were washed twice with PBS and infected with adenovirus in
fresh medium for 6–9 h to overexpress the indicated proteins. After infection,
the cells were washed twice with PBS and incubated in fresh medium. At
30–36 h after infection, the cells were treated with serum-free DMEM for 2 h
at 37°C and then incubated in uptake medium (DMEM, 2% BSA, and 20 mM
HEPES, pH 7.5) containing 2 g/ml Alexa 488-EGF (Invitrogen). After incu-
bating for 15 min at 37°C, the cells were washed twice with PBS to remove
unbound EGF and transferred to a 37°C incubator. After an additional incu-
bation for 45 min, the cells were ﬁxed and examined by confocal microscopy.
Epidermal Growth Factor Receptor Degradation
A549 cells were cultured in growth medium to 80% conﬂuency, washed
with PBS, and incubated in serum-free medium for 2 h. Epidermal growth
factor receptor (EGFR) endocytosis was stimulated by adding 100 ng/ml EGF
(Invitrogen) to the serum-free medium. At 15, 60, 120, and 180 min after EGF
stimulation, the cells were lysed with lysis buffer and subjected to immuno-
blot analysis.
Statistical Analysis
Statistical analyses were performed using a two-tailed unpaired t test. p
values  0.05 were considered statistically signiﬁcant.
RESULTS
Rubicon and PLEKHM1 Directly Interact with Rab7 via
the RH Domain
Rubicon functions in the late stage of the endocytic pathway
and in the maturation step of autophagy (Matsunaga et al.,
2009; Zhong et al., 2009). Because Rab7 is involved in both
processes (Feng et al., 1995; Gutierrez et al., 2004; Jager et al.,
2004; Stenmark, 2009), we examined whether Rubicon asso-
ciates with Rab7. As shown in Supplementary Figure S1A, a
yeast two-hybrid analysis revealed that Rubicon binds to
Figure 1. PLEKHM1 and Rubicon preferen-
tially bind directly to the GTP-bound form of
Rab7. (A) Deletion analysis of PLEKHM1 and
Rubicon. Deletion series of PLEKHM1 and
Rubicon in which the indicated deletions in
the Rubicon homology (RH) domains and
CGHL mutagenesis are shown with magenta
and asterisks (), respectively. The interac-
tions between the PLEKHM1 or Rubicon de-
letion mutants and Rab7 were examined by a
yeast two-hybrid assay. In all cases, two in-
dependent colonies were tested. (B and C)
The nucleotide dependency was examined by
an in vitro GST pulldown assay as described
in Materials and Methods. (C) Recombinant
PLEKHM1 and Rubicon proteins were de-
tected with anti-PLEKHM1 and anti-Rubicon
antibodies. GST-Rab7 was visualized by
staining with Coomassie Brilliant Blue (CBB).
(D) The relative binding amounts were quan-
tiﬁed and are shown as percentages.
K. Tabata et al.
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mutants showed that Rubicon binds to Rab7 via the C-
terminal RH domain (Figure 1A). Another RH domain–
containing protein, PLEKHM1, also interacted with Rab7.
Furthermore, PLEKHM1 speciﬁcally interacted with Rab7
through its RH domain (Supplementary Figure S1A; Figure
1A). Thus, the RH domain is a novel Rab7-binding motif that
is not similar to other known Rab7-binding motifs.
The RH domain contains a zinc ﬁnger-like motif com-
posed of nine cysteine residues and a histidine residue that
is conserved among all ﬁve human RH domain–containing
proteins (Supplementary Figure S2). We constructed a
CGHL mutant in which three cysteine residues and a histi-
dine residue in the putative core of the zinc ﬁnger-like motif
were replaced with glycine and leucine residues, respec-
tively. The CGHL mutants of PLEKHM1 and Rubicon failed
to interact with Rab7 (Figure 1A).
Rubicon only interacted with the wild-type and GTP-bound
forms (QL) (Supplementary Figure S1A; Figure 1A). However,
PLEKHM1 bound to wild-type and both the GTP-bound form
(QL) and GDP-bound form (TN) of Rab7 in the yeast two-
hybrid assay (Supplementary Figure S1A; Figure 1A) and a
coimmunoprecipitation analysis in mammalian cells (Supple-
mentary Figure S1B). To clarify the nucleotide dependency of
this interaction, we performed an in vitro binding assay with
immobilized recombinant GST-Rab7 loaded with GTPSo r
GDP analogs. As a result, recombinant PLEKHM1 strongly
interacted with the GTPS-loaded GST-Rab7, but only mini-
mally interacted with the GDP-bound form (Figure 1, B and C).
Recombinant proteins for Rubicon also preferentially inter-
Figure 2. The effects of PLEKHM1 overexpression on the en-
docytic pathway. (A and B) (A) EGFR degradation was impaired
by overexpressing PLEKHM1. A representative anti-EGFR im-
munoblot of EGF-stimulated A549 cells. The same membrane
was immunoblotted with an anti--tubulin antibody as a load-
ing control. (B) The immunodetectable levels of EGFR (relative
to -tubulin) remained constant in PKLEMH1 cells relative to
the controls (mean  SEM). (C) EGF transport was disrupted by
overexpressing PLEKHM1. EGF transport to lysosomes was
evaluated based on the colocalization of EGF and dextran. (D)
The percentages of colocalization are shown as merged EGF/
total EGF (mean  SD, n  20). Bars, 20 m. (E) The effects of
PLEKHM1 overexpression on EGF uptake. The EGF intensities
15 min after adding EGF are shown as percentages (mean  SD,
n  20). (F) Accumulation of EGF on early endosomes in PLE-
KHM1-overexpressing cells. Cells were stained with an anti-
EEA1 antibody, an early endosomal marker, and an anti-LAMP1
antibody, a late endosomal/lysosomal marker. Bars, 20 m.
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these data demonstrated that PLEKHM1 and Rubicon directly
interact with the GTP-bound form of Rab7.
PLEKHM1 Negatively Regulates Endocytic Transport But
Not Autophagic Transport
Next, we examined if PLEKHM1, like Rubicon, functions in
the endocytic and autophagic pathways. Some mutations in
PLEKHM1 are known to cause osteopetrosis (Van Wesen-
beeck et al., 2007), suggesting that PLEKHM1 plays a role in
osteoclast function. However, the mechanisms underlying
this causative link have not been elucidated. Moreover, al-
though PLEKHM1 is ubiquitously expressed, its role in
other cell types is also unknown. The ability of PLEKHM1 to
bind to Rab7, as shown in this study, and to colocalize with
late endosomal/lysosomal markers, as shown previously
(Van Wesenbeeck et al., 2007), suggest that PLEKHM1 func-
tions in the endocytic pathway.
To determine the role of PLEKHM1 in the endocytic path-
way, we ﬁrst examined the effects of PLEKHM1 overexpres-
sion on the degradation of EGFR. EGFR degradation was
signiﬁcantly delayed in PLEKHM1-overexpressing cells
compared with the controls (Figure 2, A and B). Next, we
examined the integrity of the endocytic pathway. Internal-
ized Alexa 488-EGF colocalized with lysosomes that were
stained with tetramethylrhodamine (TMR)-dextran in the
perinuclear region of control cells, but EGF minimally colo-
calized with TMR-dextran in PLEKHM1-overexpressing
cells (Figure 2, C and D). The overall incorporation of Alexa
488-EGF into cells was not signiﬁcantly affected (Figure 2E).
In PLEKHM1-overexpressing cells, internalized EGF accu-
mulated in EEA1-positive compartments but not in LAMP1-
positive compartments (Figure 2F). Lysotracker staining
showed that the endosomes in PLEKHM1-overexpressing
cells were acidic, which suggests that the effects of overex-
pression on the transport of cargo proteins were not due to
increased endosomal/lysosomal pH (Supplementary Figure
S3A). Taken together, we concluded that PLEKHM1 over-
expression inhibits the transport of EGF from early endo-
somes to lysosomes.
Next, we examined the effects of PLEKHM1 knockdown on
endocytic transport. Two PLEKHM1-speciﬁc shRNAs strongly
decreased PLEKHM1 protein expression in A549 cells (Figure
3A). We found that the total EGFR levels were already de-
creased in PLEKHM1 knockdown cells before EGF treatment
(Figure 3, A and B). The steady-state EGFR levels were signif-
icantly decreased to 40–50% of the control (Figure 3B), and this
decrease was largely due to lysosomal degradation because
lysosomal protease inhibitors blocked this decrease (Figure 3, C
and D). In addition, we kinetically measured the rate at which
Alexa 488-EGF colocalized with LAMP1 in PLEKHM1 knock-
down cells. The colocalization rates were increased compared
with the control cells at each time point (Figure 3E; Supple-
mentary Figure S4), supporting the idea that PLEKHM1 knock-
down accelerates transport to lysosomes. Thus, we concluded
that PLEKHM1 depletion constitutively enhances EGFR deg-
radation. Both the overexpression and knockdown experi-
ments are consistent with the idea that PLEKHM1 negatively
regulates the endocytic trafﬁcking of EGFR.
In addition to the endocytic pathway, Rubicon negatively
regulates the fusion between autophagosomes and lyso-
somes, and overexpressing Rubicon compromises this step
Figure 3. The effects of PLEKHM1 knock-
down on the endocytic pathway. (A and B)
The effects of PLEKHM1 knockdown on the
EGFR levels. (A) Whole cell extracts from
knockdown cells were analyzed by immuno-
blotting using the indicated antibodies. The
experiments were performed in triplicate and
a representative gel is shown. (B) Each protein
level was normalized to the -tubulin level
and expressed as a percentage relative to con-
trol. Data are shown as the mean  SEM. (C
and D) PLEKHM1 knockdown enhances the
degradation of EGFR. (C) Knockdown cells
were repeatedly treated with lysosomal inhib-
itors (1 mg/ml leupeptin and 5 g/ml E-64d)
for 50 h and subjected to immunoblotting. (D)
The EGFR levels were normalized to the -tu-
bulin levels and are shown as a percentage rel-
ative to the control. (E) The effects of knock-
down on the efﬁciency of EGF transport to
LAMP1-positive endosomes. Knocked down
cells were stained with an anti-LAMP1 anti-
body at each time point. The percentages of
colocalization are shown as merged EGF/total
EGF (mean  SD, n  20). Colocalization im-
ages are shown in Supplementary Figure S4.
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trast, GFP-LC3 colocalized to LAMP1-labeled lysosomes in
PLEKHM1-overexpressing cells, suggesting that PLEKHM1
does not affect fusion (Supplementary Figure S3B). To fur-
ther verify this ﬁnding, we examined the effects on
PLEKHM1 knockdown on autophagy ﬂux. First, we per-
formed a tfLC3 (GFP-mRFP-LC3) assay in which the ratio of
the number of red dots to that of green/red dots represents
the efﬁciency of autophagosome–lysosome fusion in tfLC3-
expressing cells. There were no differences in the ratio be-
tween the control and PLEKHM1 knockdown cells (Supple-
mentary Figure S5, A and B). Next, we monitored LC3 ﬂux
by immunoblotting. As shown in Supplementary Figure S5,
C and D, the increase in the amount of LC3 after treating
with protease inhibitors was slightly larger in PLEKHM1
knockdown cells than in control cells, but this difference was
signiﬁcantly smaller compared with Rubicon knockdown
cells. Taken together, we conclude that PLEKHM1 is not
directly involved in autophagy.
Function of PLEKHM1 and Rubicon in Endosomal
Transport Depends on Their Abilities to Bind to the
GTP-bound Form of Rab7
Given that both Rubicon and PLEKHM1 bind to Rab7 and play
a role in endosomal transport, we next examined the effects
expressing Rab7 dominant-active or -negative mutants on the
endosomal localization of Rubicon and PLEKHM1. On expres-
sion of the dominant-active Rab7 QL mutant, mStrawberry-
PLEKHM1 was increasingly recruited to endosomes with
Rab7 QL, as shown previously (Van Wesenbeeck et al., 2007;
Figure 4. The localization of PLEKHM1 and Rubicon is dependent on the Rab7 interaction. (A) The effects of coexpressing Rab7 mutants
on the localization of mStrawberry-PLEKHM1 and mStrawberry-Rubicon. HeLa cells were transiently cotransfected with the indicated
plasmids and then examined by confocal microscopy. Bars, 20 m. (B) Mutants that cannot interact with the GTP-bound form of Rab7, such
as PLEKHM1 (FL_CGHL), PLEKHM1 (1–895), and Rubicon (FL_CGHL), localize to the cytoplasm. HeLa cells were transfected with each
GFP-tagged mutant. Bars, 20 m.
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ative Rab7 TN mutant inhibited the localization of PLEKHM1 to
endosomal membranes (Figure 4A). Similarly, we also found that
the recruitment of mStrawberry-Rubicon to endosomal mem-
branes was enhanced by Rab7 QL, but inhibited by the TN
mutant (Figure 4A). Neither the dominant-negative Rab5 SN
mutant nor the Rab9 SN mutant affected the localization of
mStrawberry-Rubicon (Supplementary Figure S6). Further-
more, the non–Rab7-binding CGHL mutants of PLEKHM1
and Rubicon did not localize to endosomal membranes (Figure
4B). These data show that interactions with the GTP-bound
form of Rab7 are required for their localization to endosomes,
which is consistent with the in vitro binding assay.
To explore whether binding to Rab7 through the RH
domain is important for the function of these proteins, we
tested the effects of overexpressing the CGHL mutants on
EGF transport to lysosomes. Whereas PLEKHM1 or Ru-
bicon overexpression inhibited the transport of EGF to
TMR-labeled lysosomes (Figures 2, C and D, and 5), over-
expression of the CGHL mutants did not affect EGF trans-
port (Figure 5). Overexpression of PLEKHM1 (CGHL)
also did not affect EGFR degradation (Supplementary Fig-
ure S7A). Moreover, although wild-type overexpression
caused the endosomes to become abnormally enlarged,
overexpression of the CGHL mutant did not affect endo-
somal morphology (Supplementary Figure S3C).
Figure 5. The interactions with Rab7 are important for the regulation of the endocytic pathway. The effects of overexpressing the
non–Rab7-binding CGHL mutant on endocytic transport were evaluated by assessing the transport of EGF to lysosomes as shown in Figure
2, C and D. The percentages of colocalization are shown as merged EGF/total EGF (mean  SD, n  30). Bars, 20 m.
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con CGHL mutant did not affect autophagy induction and
autophagosome maturation (Supplementary Figure S7, B–E),
indicating that Rab7 binding is required for Rubicon to func-
tion in autophagy as well as the endocytic pathway. These
ﬁndings raise the possibility that PLEKHM1 and Rubicon act
as GTP-activating proteins for Rab7. However, our attempts to
monitor the GAP activity of the RH domain toward Rab7 in
vitro have been unsuccessful to date (Supplementary Figure S8).
Simultaneous Binding to the Beclin 1-hVps34 Complex
and Rab7 Is Critical for Rubicon Function
Although Rubicon was originally identiﬁed as a Beclin 1–bind-
ing protein (Matsunaga et al., 2009; Zhong et al., 2009), we
found that PLEKHM1 does not bind to Beclin 1 (Supplemen-
tary Figure S9). Therefore, we next examined the relationship
between the ability of Rubicon to bind to Beclin 1 and to Rab7.
First, we determined that neither the Rab7 dominant-negative
nor -active mutant affects the interaction between Rubicon and
Beclin 1 (Figure 6A). Second, we showed that the Rubicon
(CGHL) mutants could also bind to Beclin 1 (Figure 6A). These
data demonstrate that the interaction with Rab7 is not required
for the Rubicon–Beclin 1 association. Third, we examined
whether Rab7 interacts with Rubicon in the Beclin 1 complex or
only with free Rubicon. Pulldown assays with FLAG-Rab7
successfully coprecipitated endogenous Rubicon together with
Beclin 1, p150 (hVps15) and hVps34 (Figure 6, B and C). Fourth,
Rubicon knockdown conspicuously disturbed the coimmuno-
precipitation of Rab7 with Beclin 1, p150 (hVps15), and hVps34
(Figure 6, B and C). Taken together, these results suggest that
Rubicon forms a complex that includes both the Beclin 1 com-
plex and Rab7. Previous reports have shown that hVps34 as-
sociates with Rab7 via p150 (hVps15) (Stein et al., 2003; Cao et
al., 2007). Our data suggest that the ability of Rab7 to bind to
hVps34 and p150 (hVps15) is also mediated by Rubicon.
Next, we examined whether the ability of Rubicon to bind to
the Beclin 1 complex is also indispensable for Rubicon function.
The Beclin 1–binding region of Rubicon maps to a. a. residues
393–521, which contain a coiled-coil motif that is sufﬁcient to
associate with endogenous Beclin 1 (Figure 7). When the se-
quence corresponding to this Beclin 1–associating domain (BA
domain) was overexpressed in cells, endogenous Rubicon did
not coimmunoprecipitate with Beclin 1, probably due to com-
petition (Figure 7). Moreover, overexpression of the BA do-
main impaired the coimmunoprecipitation of Beclin 1 with
Rab7, although it did not affect the ability of Rubicon to bind to
Rab7 (Figure 8, A and B). Therefore, Rab7 appears to be the
only available binding partner for endogenous Rubicon in cells
that overexpress the BA domain. In these cells, EGFR degra-
dation and autophagy are signiﬁcantly accelerated (Figure 8, C
and D; Supplementary Figure S10), similar to previously re-
ported Rubicon knockdown phenotypes (Matsunaga et al.,
2009). These ﬁndings strongly suggest that even if Rab7 is
bound, loss of Beclin 1 association causes defects in Rubicon
function. Taken together, we conclude that Rubicon functions
by binding to Beclin 1 and Rab7 simultaneously.
DISCUSSION
In this study, we described a novel RH protein domain that
associates directly with Rab7. Rubicon and PLEKHM1 nega-
tively regulate endosomal transport by binding to Rab7 via
their RH domains (Figure 8E). Furthermore, this study pro-
vides novel insight into the function of PLEKHM1. These two
RH domain–containing proteins also have several signiﬁcant
differences. Rubicon must bind to the Beclin 1–PI3-kinase com-
plex in addition to Rab7 for its function, whereas PLEKHM1
only requires Rab7 binding. Rubicon, unlike PLEKHM1, is
involved in autophagosome maturation. Both of these proteins
localize to endosomes but do not show complete colocaliza-
tion. Therefore, these two RH domain proteins seem to func-
tion through different mechanisms (Figure 8E).
PLEKHM1 bound not only to wild-type Rab7 and the
Rab7QL mutant but also to the Rab7TN mutant in a yeast
Figure 6. Rubicon mediates simultaneous binding between the Be-
clin 1–PI3-kinase complex and Rab7. (A) The interaction between Be-
clin 1 and Rubicon is Rab7-independent. Lysates from HEK293A cells
expressing a Rab7 mutant, Myc-Beclin 1 and FLAG-Rubicon (wild-
type) or FLAG-Rubicon (CGHL) mutant were immunoprecipitated
with anti-FLAG M2 beads. (B and C) Rubicon mediates simultaneous
binding between the endogenous Beclin 1–PI3-kinase complex and
Rab7. (B) Lysates from knocked down cells that were transiently trans-
fected with the vector control or FLAG-Rab7 were immunoprecipi-
tated with anti-FLAG M2 beads and subjected to immunoblotting with
the indicated antibodies. (C) The immunoprecipitated protein levels in
B were quantiﬁed.
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mammalian cells, suggesting that PLEKHM1 may bind to
both the GTP-bound and GDP-bound forms of Rab7. How-
ever, the TN mutant is predicted to have reduced afﬁnity for
both GDP and GTP and may behave as a nucleotide-free
Rab7 depending on the assay conditions. Hence, in order to
determine the precise nucleotide dependence, we performed
an in vitro GST pulldown assay and found that recombinant
PLEKHM1 strongly interacted with GTPS-loaded Rab7 but
only minimally interacted with GDP-loaded Rab7. The data
convincingly conﬁrm that PLEKHM1 preferentially binds to
the GTP-bound form of Rab7, corroborating our hypothesis
that PLEKHM1, like Rubicon, is a Rab7 effector.
The structure of the RH domain appears to be important
for the recognition of Rab7. Point mutations at cysteine
residues in the RH domain abrogate the interaction with
Rab7, similar to the relationship between Rab3a and its
effector Rabphilin3a (Stahl et al., 1996). The Rab3a-binding
site in Rabphilin3a has an architecture that is similar to
the RH domain in Rubicon, including a long--helix-zinc
ﬁnger–short--helix, in which both the long and short
-helices interact with Rab3a (Ostermeier and Brunger,
1999). A mutation in the zinc ﬁnger of Rabphilin3a dis-
rupts this conﬁguration and abolishes Rab3a binding
(Stahl et al., 1996). Likewise, the RH domain structure may
be important for binding with Rab7.
How do Rubicon and PLEKHM1 negatively regulate EGF
and its receptor transport to lysosomes? It was recently
determined that Rab7 catalyzes retrograde trafﬁcking from
the endosomes to the Golgi apparatus by interacting with a
retromer complex (Rojas et al., 2008; Seaman et al., 2009).
Likewise, Rab7 may positively act in the retrieval path-
way of EGFR to the plasma membrane. When Rubicon
and PLEKHM1 are knocked down, retrieval trafﬁcking to the
plasma membrane may be impaired, leading to enhanced
trafﬁcking to the lysosomes. Alternatively, Rubicon and
PLEKHM1 may compete with other Rab7 effectors that posi-
tively function in transport to the lysosomes. The adenovirus
protein RID, which functionally mimics Rab7 and can directly
bind to the Rab7 effectors RILP and ORP1L, enhances the
lysosomal degradation of EGFR even at a resting state in the
absence of EGF activation (Shah et al., 2007). Rab7 functions in
many cell types, including osteoclasts (Zhao et al., 2001). Given
its ubiquitous expression pattern, PLEKHM1 also likely func-
tions as a universal effector of Rab7.
Previously, it was shown that Rab7 associates with hVps34
and p150 (hVps15) (Stein et al., 2003; Cao et al., 2007). In this
study, we demonstrated that Rubicon mediates this interac-
tion. Notably, the function of Rubicon in the endocytic and
autophagic pathways requires binding to both Rab7 and the
Beclin 1–PI3-kinase complex. This unique feature may allow
Rubicon to control these two membrane trafﬁcking pathways,
although its exact function remains unclear. One possibility is
that synchronized suppression of these two positive regulators
during membrane trafﬁcking guarantees that transport can be
stopped at a certain step. Rubicon may also facilitate the recy-
cling of receptors to the plasma membrane through Rab7 and
increments of local PI3P (or anchoring PI3-kinase to endo-
somes by binding to Rab7), causing a secondary reduction in
the transport to lysosomes (Matsunaga et al., 2009). This sce-
nario is analogous to earlier ﬁndings that retromer-mediated
retrograde transport from endosomes to the Golgi apparatus is
Figure 7. The Beclin 1–associating (BA) do-
main has a dominant-negative effect on Beclin 1
binding. Schematic view of the mouse Rubicon
(mRubicon) structure and its deletion mutants.
The mRubicon deletion mutants were subjected
to immunoprecipitation analyses in HEK293A
cells to map the Beclin 1–binding region.
An anti-RFP antibody was used to detect
mStrawberry (mSt) and mCherry. Lysates
from HEK293A cells expressing each plas-
mid were immunoprecipitated with an anti-
Beclin 1 antibody and immunoblotted with
an anti-Rubicon antibody. An asterisk indi-
cates a nonspeciﬁc band.
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of the cation-independent mannose 6-phosphate receptor,
EGFR, and transferrin receptor is mediated by PI3P-binding
protein, SNX1, SNX4, and SNX16 (Kurten et al., 1996; Carl-
ton et al., 2004; Choi et al., 2004; Traer et al., 2007). A previous
report demonstrated that UVRAG, a component of the Be-
clin 1 complex, binds to the HOPS complex that has GEF
activity toward Rab7 (Liang et al., 2008). Therefore, Rubicon
may terminate Rab7-dependent processes by modulating
UVRAG in the Beclin 1 complex, and this hypothesis is
supported by ﬁndings that the phenotype of the endocytic
pathway in Rubicon knockdown cells is the exact opposite
of the UVRAG knockdown phenotype (Liang et al., 2008;
Matsunaga et al., 2009).
Together, our present study provides new insights into the
regulation of the endocytic/autophagic pathway. We not only
Figure 8. The ability of Rubicon to interact with both Rab7 and Beclin 1 is important to regulate the endocytic pathway. (A and B) The effects
of overexpressing the BA domain (393–521) on the simultaneous interactions among Beclin 1, Rubicon, and Rab7. (A) Coimmunoprecipitation
of endogenous Beclin 1 with Rab7 was disrupted in HEK293A cells overexpressing the BA domain, whereas Rubicon coimmunoprecipitated
with Rab7 in these cells. An asterisk indicates a nonspeciﬁc band. (B) Immunoprecipitated protein levels in A were quantiﬁed. (C and D) The
effects of overexpressing the BA domain on EGFR degradation. (C) EGFR levels were monitored in A549 cells overexpressing the BA domain
as shown in Figure 2A. (D) Immunodetectable levels of EGFR (relative to -tubulin) remained constant in cells overexpressing the BA domain
relative to the controls (mean  SEM). An anti-RFP antibody was used to detect mCherry-mRubicon (393–521). (E) PLEKHM1 and Rubicon
negatively regulate the endocytic pathway through their interactions with Rab7. Their interactions with Rab7 are also required for their
localization to endosomal membranes. Rubicon mediates the simultaneous interaction between the Beclin 1–PI3-kinase complex and Rab7,
which is an important step in the regulation of the endocytic pathway and autophagosome maturation.
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Vol. 21, December 1, 2010 4171identiﬁed new Rab7 effectors but also discovered a direct con-
nection between two key players in membrane trafﬁc, a Rab
protein and PI3-kinase. Rab7 and PI3-kinase function at spe-
ciﬁc stages in a concerted manner through Rubicon.
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